Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer

Familial Cancer

Volumn 10, Issue 3, 2011, Pages 545-548

  Yang, Xiaohong R ^a   Jessop, Lea ^a   Myers, Timothy ^a,b   Amundadottir, Laufey ^a   Pfeiffer, Ruth M ^a   Wheeler, William ^c   Pike, Kristen M ^b   Yuenger, Jeff ^a,b   Burdett, Laurie ^a,b   Yeager, Meredith ^a,b   Chanock, Stephen J ^a   Tucker, Margaret A ^a   Goldstein, Alisa M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

CDKN2A; Familial melanoma; Germline mutation; PALB2; Pancreatic cancer

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

CANCER RISK; CONFERENCE PAPER; GENE MUTATION; HUMAN; MELANOMA; PALB2 GENE; PANCREAS CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MELANOMA; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 80054970194     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9447-9     Document Type: Conference Paper

References (15)

1. NK Hayward 2003 Genetics of melanoma predisposition Oncogene 22 20 3053 3062 12789280 10.1038/sj.onc.1206445 1:CAS:528:DC%2BD3sXkt12qtbg%3D May 19 (Pubitemid 36713755)
2. AM Goldstein M Chan M Harland, et al. 2006 High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL Cancer Res 66 20 9818 9828 17047042 10.1158/0008-5472. CAN-06-0494 1:CAS:528:DC%2BD28XhtVyiur3M Oct 15 (Pubitemid 44672032)
3. AM Goldstein M Chan M Harland, et al. 2007 Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents J Med Genet 44 2 99 106 16905682 10.1136/jmg.2006.043802 1:CAS:528:DC%2BD2sXjt1Sntr4%3D
4. S Jones RH Hruban M Kamiyama, et al. 2009 Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene Science 324 5924 217 19264984 10.1126/science.1171202 1:CAS:528:DC%2BD1MXktFalsr0%3D Apr 10
5. B Xia Q Sheng K Nakanishi, et al. 2006 Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2 Mol Cell 22 6 719 729 16793542 10.1016/j.molcel.2006.05.022 1:CAS:528:DC%2BD28XmvVCitL8%3D Jun 23
6. The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91(15):1310-1316
7. AM Goldstein MT Landi S Tsang MC Fraser DJ Munroe MA Tucker 2005 Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations Cancer Epidemiol Biomarkers Prev 14 9 2208 2212 16172233 1:CAS:528:DC%2BD2MXhtVWgtbrL (Pubitemid 41603269)
8. AM Goldstein JP Struewing A Chidambaram MC Fraser MA Tucker 2000 Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations J Natl Cancer Inst 92 12 1006 1010 10861313 10.1093/jnci/92.12. 1006 1:STN:280:DC%2BD3czitV2ntA%3D%3D Jun 21 (Pubitemid 30469967)
9. AM Goldstein 2004 Familial, melanoma, pancreatic cancer, and germline CDKN2A mutations Hum Mutat 23 6 630 15146471 10.1002/humu.9247
10. CS Carlson MA Eberle MJ Rieder Q Yi L Kruglyak DA Nickerson 2004 Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium Am J Hum Genet 74 1 106 120 14681826 10.1086/381000 1:CAS:528:DC%2BD2cXlvVOrsA%3D%3D (Pubitemid 38085242)
11. RM Pfeiffer A Hildesheim MH Gail, et al. 2003 Robustness of inference on measured covariates to misspecification of genetic random effects in family studies Genet Epidemiol 24 1 14 23 12508252 10.1002/gepi.10191 (Pubitemid 36077398)
12. F Dudbridge BP Koeleman 2003 Rank truncated product of P-values, with application to genomewide association scans Genet Epidemiol 25 4 360 366 14639705 10.1002/gepi.10264 (Pubitemid 37486884)
13. Sabbaghian N, Kyle R, Hao A, Hogg D, Tischkowitz M (2010) Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma. Fam Cancer. doi: 10.1007/s10689-010-9405-y
14. Hofstatter EW, Domchek SM, Miron A, Garber J, Wang M, Componeschi K, Boghossian L, Miron PL, Nathanson KL, Tung N (2011) PALB2 mutations in familial breast and pancreatic cancer. Fam Cancer. doi: 10.1007/s10689-011-9426-1
15. Stadler ZK, Salo-Mullen E, Sabbaghian N, Simon JA, Zhang L, Olson SH, Kurtz R, Offit K, Foulkes WD, Robson ME, Tischkowitz M (2011) Germline PALB2 mutation analysis in breast-pancreas cancer families. J Med Genet. doi: 10.1136/jmg.2010.087379